Molecular profiling of bladder cancer xenografts defines relevant molecular subtypes and provides a resource for biomarker discovery.
Sharada Mokkapati(The University of Texas MD Anderson Cancer Center), David J. McConkey(Johns Hopkins University), Côme Tholomier(The University of Texas MD Anderson Cancer Center), Alexis Steinmetz, Byron Lee(Vanderbilt University Medical Center), Ganiraju C. Manyam(The University of Texas MD Anderson Cancer Center), Colin P. Dinney(The University of Texas MD Anderson Cancer Center), Woonyoung Choi(The University of Texas MD Anderson Cancer Center), Alberto Martini(The University of Texas MD Anderson Cancer Center)
Cited by 4
Related Papers
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
|Cell|2016|2.4k
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
|European Urology|2019|1.4k